Publications by authors named "Max Liebau"

Claim this Profile
Q
Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives.
Belle Soyfer, Sorin Fedeles, Wendy Ruyle, Elise Hoover, Max C Liebau

Kidney Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-Associated Kidney Dysplasia and Podocyte Injury: 2 Faces of a Monogenic Disorder.
Stefan Kohl, Max C Liebau

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KDIGO 2025 ADPKD guideline through pediatric eyes.
Olil E Van Reeth, Melissa A Cadnapaphornchai, Max C Liebau, Amy Earley, Vicente Torres

Pediatr Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycystic Kidney Disease in Children: The Current Status and the Next Horizon.
Melissa A Cadnapaphornchai, Katherine M Dell, Charlotte Gimpel, Lisa M Guay-Woodford, Ashima Gulati, Max C Liebau

Am J Kidney Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks and benefits of ChatGPT in informing patients and families with rare kidney diseases: an explorative assessment by the European Rare Kidney Disease Reference Network (ERKNet).
Albertien M van Eerde, Ana Teixeira, Flavia Galletti, Michal Maternik, Valentina Capone, Max C Liebau

Pediatr Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nephronophthisis protein / is required for the DNA damage response in kidney tubular epithelial cells.
Lena K Ebert, Lukas Schloesser, Laura E Frech, Manaswita Jain, Claudia Dafinger, Max C Liebau

Am J Physiol Renal Physiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition of patients with hereditary nephropathies from pediatric to adult care.
Maria Vanessa Perez Gomez, George-Claudiu Costea, Laura Claus, Emilie Cornec-Le Gall, Albertien M van Eerde, Max C Liebau

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we ACE-ing the early treatment of Alport syndrome?
Samantha J Williamson, Max Liebau, R Rachel Lennon

Pediatr Nephrol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis.
Sandra Habbig, Hanna Debiec, Malha Chedik, Dirk L Stippel, Florian Erger, Max C Liebau

Kidney Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndrome.
Jan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, Lars Pape, Kay Latta, Max C Liebau

Pediatr Nephrol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countries.
Charlotte Gimpel, Steffen Fieuws, Jonas Hofstetter, David Pitcher, Lotte Vanmeerbeek, Max C Liebau

Kidney Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Bbs8 leads to cystic kidney disease in mice with reduced acetylation of ciliary alpha-tubulin through HDAC2.
Emilia Kieckhöfer, Julia Günzler, Peter A Matthiessen, Lena K Ebert, Christina Klausen, Max C Liebau

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A risk score to predict kidney survival in patients with autosomal recessive polycystic kidney disease at the age of two months.
Kathrin Burgmaier, Samuel Kilian, Klaus Arbeiter, Bahriye Atmis, Olivia Boyer, Max Christoph Liebau

Kidney Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease.
Kathrin Burgmaier, Bénédicte Buffin-Meyer, Julie Klein, Brian Becknell, Daryl McLeod, Max C Liebau

Clin Kidney J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.
Vicente E Torres, Curie Ahn, Thijs R M Barten, Godela Brosnahan, Melissa A Cadnapaphornchai, Max C Liebau

Kidney Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Dickkopf-3 Reflects Disease Severity and Predicts Short-Term Kidney Function Decline in Renal Ciliopathies.
Mareike Dahmer-Heath, Joachim Gerß, Danilo Fliser, Max Christoph Liebau, Thimoteus Speer

Kidney Int Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal and Extrarenal Phenotypes in Patients With Variants and Chromosome 17q12 Microdeletions.
Bénédicte Buffin-Meyer, Juliette Richard, Vincent Guigonis, Stefanie Weber, Jens König, Max C Liebau

Kidney Int Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of MYC expression by in human and mouse kidneys: phenotypic implications for recessive polycystic kidney disease.
Naoe Harafuji, Chaozhe Yang, Maoqing Wu, Girija Thiruvengadam, Heather Gordish-Dressman, Max C Liebau

Front Cell Dev Biol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autosomal Recessive Polycystic Kidney Disease: Diagnosis, Prognosis, and Management.
Kathrin Burgmaier, Ilse J Broekaert, Max C Liebau

Adv Kidney Dis Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAPT1-at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta.
Julia Etich, Oliver Semler, Nicola L Stevenson, Alice Stephan, Roberta Besio, Max Christoph Liebau

EMBO Mol Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Courses of Patients With Autosomal Recessive Polycystic Kidney Disease-Mimicking Phenocopies.
Abdul A Halawi, Kathrin Burgmaier, Anja K Buescher, Ismail Dursun, Florian Erger, Max C Liebau

Kidney Int Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shift from severe hypotension to salt-dependent hypertension in a child with autosomal recessive polycystic kidney disease after bilateral nephrectomies: a case report.
Dovile Ruzgiene, Lauryna Abraityte, Karolis Azukaitis, Max Christoph Liebau, Augustina Jankauskiene

BMC Nephrol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Low-Cost Sequencing Platform for Rapid Genotyping in ADPKD and its Impact on Clinical Care.
Christoph Heinrich Lindemann, Andrea Wenzel, Florian Erger, Lea Middelmann, Julika Borde, Max Christoph Liebau

Kidney Int Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal and Perinatal Nephrology: Small but Mighty.
Stefan Kohl, Max C Liebau

Kidney360· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis